Cyclooxygenase-2 mediates interleukin-6 upregulation by vomitoxin (deoxynivalenol) in vitro and in vivo

Toxicology and Applied Pharmacology

Volumn 187, Issue 2, 2003, Pages 80-88

  Moon, Yuseok ^a   Pestka, James J ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

COX 2; Immunotoxicity; Mycotoxin; Prostaglandin; Trichothecene

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; INTERLEUKIN 6; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; VOMITOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEEDING; GENE EXPRESSION; HYPOTHESIS; IMMUNOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MACROPHAGE; MALE; METABOLITE; MOUSE; NONHUMAN; PEYER PATCH; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SPLEEN; STATISTICAL SIGNIFICANCE; UPREGULATION; WILD TYPE;

MURINAE;

EID: 0037339515     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-008X(02)00033-9     Document Type: Article

References (71)

1. Abouzied M.M., Azcona J.I., Braselton W.E., Pestka J.J. Immunochemical assessment of mycotoxins in 1989 grain foods evidence for deoxynivalenol (vomitoxin) contamination . Appl. Environ. Microbiol. 57:1991;672-677.
2. Anderson G.D., Hauser S.D., McGarity K.L., Bremer M.E., Isakson P.C., Gregory S.A. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J. Clin. Invest. 97:1996;2672-2679.
3. Arakawa T., Laneuville O., Miller C.A., Lakkides K.M., Wingerd B.A., DeWitt D.L., Smith W.L. Prostanoid receptors of murine NIH 3T3 and RAW 264.7 cells structure and expression of the murine prostaglandin EP4 receptor gene . J. Biol. Chem. 271:1996;29569-29575.
4. Beagley K.W., Eldridge J.H., Aicher W.K., Mestecky J., Di Fabio S., Kiyono H., McGhee J.R. Peyer's patch B cells with memory cell characteristics undergo terminal differentiation within 24 hours in response to interleukin-6. Cytokine. 3:1991;107-116.
5. Beagley K.W., Eldridge J.H., Lee F., Kiyono H., Everson M.P., Koopman W.J., Hirano T., Kishimoto T., McGhee J.R. Interleukins and IgA synthesis human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells . J. Exp. Med. 169:1989;2133-2148.
6. Betz M., Fox B.S. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146:1991;108-113.
7. Bhat R.V., Beedu S.R., Ramakrishna Y., Munshi K.L. Outbreak of trichothecene mycotoxicosis associated with consumption of mould-damaged wheat production in Kashmir Valley, India. Lancet. 1:1989;35-37.
8. Chen W.P., Chen A., Lin C.Y. In vitro effects of interleukins on human mesangial cells implications for glomerulonephritis . J. Pathol. 175:1995;327-337.
9. Clarkson A.R., Woodroffe A.J., Aarons I., Hiki Y., Hale G. IgA nephropathy. Annu. Rev. Med. 38:1987;157-168.
10. Coppo R., Basolo B., Rollino C., Roccutello D., Martina G., Amore A., Bongiorno G., Piccoli G. Mediterranean diet and primary IgA nephropathy. Clin. Nephrol. 26:1986;77-82.
11. D'Amico G.D. The commonest glomerulonephritis in the world. Q.J. Med. 64:1987;709-727.
12. Dendorfer U., Oettgen P., Libermann T.A. Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Mol. Cell. Biol. 14:1994;4443-4454.
13. Dong W., Pestka J.J. Persistent dysregulation of IgA production and IgA nephropathy in the B6C3F1 mouse following withdrawal of dietary vomitoxin (deoxynivalenol). Fundam. Appl. Toxicol. 20:1993;38-47.
14. Dong W., Sell J.E., Pestka J.J. Quantitative assessment of mesangial immunoglobulin A (IgA) accumulation, elevated circulating IgA immune complexes, and hematuria during vomitoxin-induced IgA nephropathy. Fundam. Appl. Toxicol. 17:1991;197-207.
15. Ebihara I., Hirayama K., Yamamoto S., Muro K., Yamagata K., Koyama A. Th2 predominance at the single-cell level in patients with IgA nephropathy. Nephrol. Dial. Transplant. 16:2001;1783-1789.
16. Emancipator S.N., Lamm M.E. IgA nephropathy: pathogenesis of the most common form of glomerulonephritis. Lab. Invest. 60:1989;168-183.
17. Fedyk E.R., Brown D.M., Phipps R.P. PGE2 regulation of B lymphocytes and T helper 1 and T helper 2 cells induction of inflammatory versus allergic responses . Adv. Exp. Med. Biol. 407:1997;237-242.
18. Fletcher B.S., Kujubu D.A., Perrin D.M., Herschman H.R. Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase. J. Biol. Chem. 267:1992;4338-4344.
19. Forsell J.H., Jensen R., Tai J.-H., Witt M., Lin W.S., Pestka J.J. Comparison of acute toxicity of deoxynivalenol (vomitoxin) and 15-acetyl deoxynivalenol in the B6C3F1 mouse. Food Chem. Toxicol. 25:1987;155-162.
20. Forsell J.H., Witt M.F., Tai J.H., Jensen R., Pestka J.J. Effects of 8-week exposure of the B6C3F1 mouse to dietary deoxynivalenol (vomitoxin) and zearalenone. Food Chem. Toxicol. 24:1986;213-219.
21. Fujihashi K., Kono Y., Kiyono H. Effects of IL-6 on B cells in mucosal immune response and inflammation. Res. Immunol. 143:1992;744-749.
22. Futaki N., Arai I., Hamasaka Y., Takahashi S., Higuchi S., Otomo S. Selective inhibition of NS-398 on prostanoid production in inflammed tissue in rat carrageenan-air-pouch inflammation. J. Pharm. Pharmacol. 45:1993;753-755.
23. Futaki N., Takahashi S., Yokoyama M., Arai I., Higuchi S., Otomo S. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins. 47:1994;55-59.
24. Futaki N., Yoshikawa K., Hamasaka Y., Arai I., Higuchi S., Iizuka H., Otomo S. NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. Gen. Pharmacol. 24:1993;105-110.
25. Greene D.M., Azcona-Olivera J.I., Murtha J.M., Pestka J.J. Effects of dihydrotestosterone and estradiol on experimental IgA nephropathy induced by vomitoxin. Fundam. Appl. Toxicol. 26:1995;107-116.
26. Greene D.M., Azcona-Olivera J.I., Pestka J.J. Vomitoxin (deoxynivalenol)-induced IgA nephropathy in B6C3F1 mouse dose response and male predilection . Toxicology. 92:1994;245-260.
27. Hall L.L., Bicknell G.R., Primrose L., Pringle J.H., Shaw J.A., Furness P.N. Reproducibility in the quantification of mRNA levels by RT-PCR-ELISA and RT competitive-PCR-ELISA. Biotechniques. 24:1998;652-658.
28. Harris S.G., Padilla J., Koumas L., Ray D., Phipps R.P. Prostaglandins as modulators of immunity. Trends Immunol. 23:2002;144-150.
29. Hellegars, D., 1993. IgA nephropathy. Partners in Prevention (Spring), p. 10.
30. Hinson R.M., Williams J.A., Shacter E. Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation possible role of cyclooxygenase-2 . Proc. Natl. Acad. Sci. USA. 93:1996;4885-4890.
31. Islam Z., Moon Y.S., Zhou H.R., King L.E., Fraker P.J., Pestka J.J. Endotoxin potentiation of trichothecene-induced lymphocyte apoptosis is mediated by up-regulation of glucocorticoids. Toxicol. Appl. Pharmacol. 180:2002;43-55.
32. Ji G.E., Park S.Y., Wong S.S., Pestka J.J. Modulation of nitric oxide, hydrogen peroxide, and cytokine production in clonal macrophage model by the trichothecene vomitoxin (deoxynivalenol). Toxicology. 125:1998;203-214.
33. Kalinski P., Vieira P.L., Schuitemaker J.H., de Jong E.C., Kapsenberg M.L. Prostaglandin E2 is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood. 97:2001;3466-3469.
34. Kozawa O., Suzuki A., Tokuda H., Kaida T., Uematsu T. Interleukin-6 synthesis induced by prostaglandin E2 cross-talk regulation by protein kinase C . Bone. 22:1998;355-360.
35. Kuroda E., Sugiura T., Zeki K., Yoshida Y., Yamashita U. Sensitivity difference to the suppressive effect of prostaglandin E2 among mouse strains a possible mechanism to polarize Th2 type response in BALB/c mice . J. Immunol. 164:2000;2386-2395.
36. Langenbach R., Loftin C.D., Lee C., Tiano H. Cyclooxygenase-deficient mice a summary of their characteristics and susceptibilities to inflammation and carcinogenesis . Ann. NY Acad. Sci. 889:1999;52-61.
37. Laskin J.D., Heck D.E., Laskin D.L. The ribotoxic stress response as a potential mechanism for MAP kinase activation in xenobiotic toxicity. Toxicol. Sci. 69:2002;289-291.
38. Lim C.S., Zheng S., Kim Y.S., Ahn C., Han J.S., Kim S., Lee J.S., Chae D.W., Koo J.R., Chun R.W., Noh J.W. Th1/Th2 predominance and proinflammatory cytokines determine the clinicopathological severity of IgA nephropathy. Nephrol. Dial. Transplant. 16:2001;269-275.
39. McGhee J.R., Fujihashi K., Beagley K.W., Kiyono H. Role of interleukin-6 in human and mouse mucosal IgA plasma cell responses. Immunol. Res. 10:1991;418-422.
40. Meyer T.A., Noguchi Y., Ogle C.K., Tiao G., Wang J.J., Fischer J.E., Hasselgren P.O. Endotoxin stimulates interleukin-6 production in intestinal epithelial cells. A synergistic effect with prostaglandin E2. Arch. Surg. 129:1994;1290-1294.
41. Meyer T.A., Wang J., Tiao G.M., Ogle C.K., Fischer J.E., Hasselgren P.O. Sepsis and endotoxemia stimulate intestinal interleukin-6 production. Surgery. 118:1995;336-342.
42. Moon Y., Pestka J.J. Vomitoxin-induced cyclooxygenase-2 gene expression in macrophages mediated by activation of ERK and p38 but not JNK mitogen-activated protein kinases. Toxicol. Sci. 69:2002;373-382.
43. Myers L.K., Kang A.H., Postlethwaite A.E., Rosloniec E.F., Morham S.G., Shlopov B.V., Goorha S., Ballou L.R. The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis. Arthritis Rheum. 43:2000;2687-2693.
44. Newton R., Seybold J., Kuitert L.M., Bergmann M., Barnes P.J. Repression of cyclooxygenase-2 and prostaglandin E2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA. J. Biol. Chem. 273:1998;32312-32321.
45. Newton R., Seybold J., Liu S.F., Barnes P.J. Alternate COX-2 transcripts are differentially regulated implications for post-transcriptional control. Biochem . Biophys. Res. Commun. 234:1997;85-89.
46. Newton R., Stevens D.A., Hart L.A., Lindsay M., Adcock I.M., Barnes P.J. Superinduction of COX-2 mRNA by cycloheximide and interleukin-1beta involves increased transcription and correlates with increased NF-κB and JNK activation. FEBS Lett. 418:1997;135-138.
47. Pestka J.J., Moorman M.A., Warner R.L. Dysregulation of IgA production and IgA nephropathy induced by the trichothecene vomitoxin. Food Chem. Toxicol. 27:1989;361-368.
48. Pestka J.J., Zhou H.R. Interleukin-6-deficient mice refractory to IgA dysregulation but not anorexia induction by vomitoxin (deoxynivalenol) ingestion. Food Chem. Toxicol. 38:2000;565-575.
49. Rasooly L., Abouzied M.M., Brooks K.H., Pestka J.J. Polyspecific and autoreactive IgA secreted by hybridomas derived from Peyer's patches of vomitoxin-fed mice characterization and possible pathogenic role in IgA nephropathy . Food Chem. Toxicol. 32:1994;337-348.
50. Rasooly L., Pestka J.J. Polyclonal autoreactive IgA increase and mesangial deposition during vomitoxin-induced IgA nephropathy in the BALB/c mouse. Food. Chem. Toxicol. 32:1994;329-336.
51. Ricote M., Li A.C., Willson T.M., Kelly C.J., Glass C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature. 391:1998;79-82.
52. Riedy M.C., Timm E.A. Jr., Stewart C.C. Quantitative RT-PCR for measuring gene expression. Biotechniques. 18:1995;70-74. 76.
53. Rotter B.A., Prelusky D.B., Pestka J.J. Toxicology of deoxynivalenol (vomitoxin). J. Toxicol. Environ. Health. 48:1996;1-34.
54. Scott P.M. Trichothecenes in grains. Cereal Foods World. 35:1990;661-666.
55. Smith W.L., DeWitt D.L., Garavito R.M. Cyclooxygenases structural, cellular, and molecular biology . Annu. Rev. Biochem. 69:2000;145-182.
56. Snijdewint F.G., Kalinski P., Wierenga E.A., Bos J.D., Kapsenberg M.L. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J. Immunol. 150:1993;5321-5329.
57. Taniguchi Y., Yorioka N., Kumagai J., Katsutani M., Kuratsune M., Amimoto D., Yamakido M. Interleukin-6 localization and the prognosis of IgA nephropathy. Nephron. 81:1999;94-98.
58. Tavakoli S., Cowan M.J., Benfield T., Logun C., Shelhamer J.H. Prostaglandin E(2)-induced interleukin-6 release by a human airway epithelial cell line. Am. J. Physiol. Lung Cell Mol. Physiol. 280:2001;L127-L133.
59. Tegeder I., Neupert W., Guhring H., Geisslinger G. Effects of selective and unselective cyclooxygenase inhibitors on prostanoid release from various rat organs. J. Pharmacol. Exp. Ther. 292:2000;1161-1168.
60. Ueno Y. General toxicology. Ueno Y. Trichothecenes: Chemical, Biological and Toxicological Aspects. 1983;135-1446 Elsevier, New York.
61. Vane J.R., Bakhle Y.S., Botting R.M. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol. 38:1998;97-120.
62. Warner R.L., Brooks K.H., Pestka J.J. In vivo effects of vomitoxin (deoxynivalenol) on T-cell interleukin production and IgA secretion. Food Chem. Toxicol. 32:1994;617-625.
63. Williams J.A., Pontzer C.H., Shacter E. Regulation of macrophage interleukin-6 (IL-6) and IL-10 expression by prostaglandin E2 the role of p38 mitogen-activated protein kinase . J. Interferon Cytokine Res. 20:2000;291-298.
64. Williams J.A., Shacter E. Regulation of macrophage cytokine production by prostaglandin E2 distinct roles of cyclooxygenase-1 and -2 . J. Biol. Chem. 272:1997;25693-25699.
65. Wong S., Schwartz R.C., Pestka J.J. Superinduction of TNF-alpha and IL-6 in macrophages by vomitoxin (deoxynivalenol) modulated by mRNA stabilization. Toxicology. 161:2001;139-149.
66. Wong S.S., Zhou H.R., Marin-Martinez M.L., Brooks K., Pestka J.J. Modulation of IL-1beta, IL-6 and TNF-alpha secretion and mRNA expression by the trichothecene vomitoxin in the RAW 264.7 murine macrophage cell line. Food Chem. Toxicol. 36:1998;409-419.
67. Yan D., Zhou H.R., Brooks K.H., Pestka J.J. Potential role for IL-5 and IL-6 in enhanced IgA secretion by Peyer's patch cells isolated from mice acutely exposed to vomitoxin. Toxicology. 122:1997;145-158.
68. Yan D., Zhou H.R., Brooks K.H., Pestka J.J. Role of macrophages in elevated IgA and IL-6 production by Peyer's patch cultures following acute oral vomitoxin exposure. Toxicol. Appl. Pharmacol. 148:1998;261-273.
69. Zeng L., An S., Goetzl E.J. EP4/EP2 receptor-specific prostaglandin E2 regulation of interleukin-6 generation by human HSB.2 early T cells. J. Pharmacol. Exp. Ther. 286:1998;1420-1426.
70. Zhou H.R., Harkema J.R., Yan D., Pestka J.J. Amplified proinflammatory cytokinc expression and toxicity in mice coexposed to lipopolysaccharide and the trichothecene vomitoxin (deoxynivalenol). J. Toxicol. Environ. Health Part A. 57:1999;115-136.
71. Zhou H.R., Yan D., Pestka J.J. Differential cytokine mRNA expression in mice after oral exposure to the trichothecene vomitoxin (deoxynivalenol) dose response and time course . Toxicol. Appl. Pharmacol. 144:1997;294-305.